Name: TXMD Balance Sheet - Therapeuticsmd Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

TXMD - Therapeuticsmd, Inc.

USD | NASDAQ | Healthcare

TXMD Balance Sheet - Therapeuticsmd Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Cash And Short Term Investments
Cash And Equivalents	-	5.1	4.3	-	-	-	-	-	-	-	-	-	-	-	0.1	0.4	-
Restricted Cash	-	-	-	11.3	-	-	-	-	-	-	-	-	-	-	-	-	-
Short Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	-	5.1	4.3	-	-	-	-	-	-	-	-	-	-	-	0.1
Receivables
Accounts Receivable	-	-	-	-	36.2	32.4	24.4	11.1	4.3	4.5	3.0	2.2	1.7	0.7	0.0
Current Assets
Inventory	-	-	-	-	7.6	8.0	11.9	3.3	1.5	1.1	0.7	1.2	1.0	1.6	0.6	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	2.5	2.5	2.8	3.7	3.5	1.0	0.8	0.7	0.4	0.2	0.2	0.1
Current Liabilities
Accounts Payable	0.4	0.3	0.0	2.2	3.4	21.1	19.2	22.7	4.1	7.4	3.1	6.3	2.1	1.6	0.3
Non-Current Liabilities
Long Term Debt	-	-	-	-	0.0	237.7	194.6	73.4	-	-	-	-	-	-	-	-
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	-
Supplementary Data
Total Debt	-	-	-	-	188.3	237.7	194.6	73.4	-	-	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)